申请人:Alper Phillip B.
公开号:US20100022515A1
公开(公告)日:2010-01-28
The invention provides compounds, pharmaceutical compositions comprising compound of following formula (I), and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119 (G protein-coupled receptor 119) such as obesity, diabetes and hyperlipidemia.
本发明提供了以下式子(I)的化合物、含有该化合物的制药组合物,以及使用这些化合物治疗或预防与GPR119(G蛋白偶联受体119)活性相关的疾病或症状的方法,例如肥胖症、糖尿病和高脂血症。